Overview

Characterization of the Temporo-masseteric Nerve Block (TMNB) in Healthy Subjects

Status:
Not yet recruiting
Trial end date:
2023-03-31
Target enrollment:
0
Participant gender:
All
Summary
The proposed pilot study is aimed at preliminary characterization of the TMNB injection in 20 healthy volunteers. Assessment of bite-force distribution and surface electromyographic activity of the temporalis and the masseter muscles, at rest and clench, before and after unilateral TMNB injection, will be the primary outcome measures. Post-injection assessments will be performed at 30 minutes, 2 hours, and 2 weeks after the injection. Participants will be surveyed regarding their experience receiving the TMNB injection (secondary outcomes).
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Rutgers, The State University of New Jersey
Criteria
Inclusion Criteria:

- 18-64 years of age

- All ethnicity

- Male and female sex

- Fluent in written/spoken English

- Never been diagnosed with TMD

- No significant history of orofacial pain

- <5 headaches/month in the 3 months before enrollment

- No reported use of a nightguard or occlusal splint 'No' to all questions on
self-administered questionnaire for TMD screening:

- Pain in jaw or temple on either side of the face in the last 30 days

- Stiffness or pain in jaw upon awakening in the last 30 days

- Any pain increase/reduction in the jaw/temple region during the last 30 days with

- Chewing hard or tough food

- Opening mouth or moving jaw forward or to the side

- Hold teeth together/clenching/grinding/chewing gum

- Using the jaw during activities such as talking, kissing or yawning

Exclusion Criteria:

- Traumatic injury/ surgery on face or jaw < 6 months

- current orthodontic treatment

- pregnant or nursing,

- kidney failure or renal dialysis,

- heart disease or heart failure,

- uncontrolled chronic respiratory disease/ hypertension/ diabetes

- history of

- seizures

- hyperthyroidism

- drug or alcohol abuse

- psychiatric disorder/conditions requiring hospitalization

- chemotherapy/radiation